Skip to content
Evidence-Based & Medically Referenced

SIBO and Rosacea: What the Studies Show About Skin and Gut

By Bacterial Overgrowth Editorial Team Published 4 min reading time
SIBO and Rosacea: What the Studies Show About Skin and Gut

In short: several studies have found SIBO more often in people with rosacea than in people without it. A 2025 meta-analysis of 6 studies put the rate at about 36% in rosacea compared with 9% in controls2. In one 2008 trial, clearing SIBO with the antibiotic rifaximinRifaximin An antibiotic that is barely absorbed into the bloodstream, so it acts mainly inside the gut. It is a common prescription treatment for SIBO. cleared or greatly improved the skin in most patients, although the doctors rating the skin knew who had been treated1. The evidence is not consistent, though: a 2015 study found no more SIBO in rosacea than in controls3, and no large, fully blinded trial has tested SIBO treatment for rosacea.

Rosacea is a long-term skin condition that causes facial redness, visible blood vessels and sometimes pimple-like bumps. This guide covers what the research on SIBO and rosacea shows, how strong it is, and what is known about other skin conditions.

How common is SIBO in rosacea?

Study Who was tested SIBO in rosacea vs. controls
2008, Italy 113 people with rosacea and 60 matched controls; lactulose and glucose breath tests 52 of 113 (46%) vs. 3 of 60 (5%)1
2015, Italy 90 people with rosacea and 90 controls; glucose breath test 10% vs. 7.8%, no real difference3
2024, USA 27 people with rosacea and no gut disease or recent antibiotics; glucose breath test 33% (9 of 27), compared with estimates for the general population; no control group4
2025 meta-analysis 6 studies, 581 people with rosacea and 220 controls 35.8% vs. 9.4%; 3.5 times the risk2

Part of the disagreement may come from the tests used: the 2008 study used both lactuloseLactulose A synthetic sugar the body cannot digest or absorb. As a breath-test substrate it travels the whole small intestine, which also makes false positives more likely. and glucose breath tests, while the 2015 study used only the glucose test13. The two tests do not always agree; see breath tests explained. The 2024 study’s authors also note that it is unclear whether SIBO contributes to rosacea or whether both are results of a shared problem with the immune system4.

Does treating SIBO help rosacea?

The best-known study is the 2008 trial from Genoa1:

  • People with rosacea and a positive breath test were randomized to rifaximin (1,200 mg a day for 10 days) or a placebo.
  • In the 28 whose SIBO was cleared by rifaximin, the skin cleared in 20 and greatly improved in 6 more. Of the 20 on placebo, 18 stayed the same and 2 got worse.
  • When the placebo group was switched to rifaximin, SIBO cleared in 17 of 20, and 15 had complete resolution of rosacea.
  • In people with a negative breath test, rifaximin did not help: 13 of 16 stayed the same.
  • The improvement lasted at least 9 months.

These results are striking, but the trial has an important limit: the two dermatologists who rated the skin knew which treatment each patient had received1. The 2025 meta-analysis pooled the treatment results and found that rifaximin improved or cleared rosacea in 57.9% of patients, and in up to 85.7% of those whose SIBO was cleared2. That meta-analysis is published in Russian, so we could assess only its English abstract, and it included only 6 studies.

In the 2015 study, where SIBO was no more common in rosacea, 6 of the 7 people whose SIBO was cleared had a marked improvement in their skin, but the numbers were too small to draw conclusions3. The same study found that Helicobacter pylori infection was much more common in rosacea (49% vs. 27%), and that clearing it led to improvement in 35 of 36 people3. See our guide to H. pylori and SIBO.

Herbal treatment

A 2024 open-label study gave 16 adults with SIBO a combination of herbal supplements for 10 weeks. Participants were chosen because they had SIBO, not rosacea, and the researchers measured facial redness with photographs. Facial redness fell by 20% at week 10, though it had not changed at week 6 and did not change further in those who continued to week 145. The study had no control group and 4 people dropped out. The supplements were provided by their manufacturer, and the senior author has consulted for skincare and pharmaceutical companies5. Treat it as a pilot result. For what is known about herbal SIBO treatments in general, see herbal antimicrobials.

Should people with rosacea be tested for SIBO?

We found no guideline that recommends routine SIBO testing for rosacea. Testing makes most sense if you also have digestive symptoms such as bloating, abdominal pain or a change in bowel habits; see SIBO symptoms and our diagnosis guide. Rifaximin did not help rosacea in people without SIBO in the 2008 trial1, so treating SIBO “just in case” is not supported. Standard rosacea treatment from a dermatologist remains the first step.

Other skin conditions

  • Chronic hives (urticaria). In a 2013 study of 48 people with chronic spontaneous urticaria, 13 had SIBO. Treating it did not improve their hives, while treating H. pylori in 11 people did6.
  • Acne, eczema and psoriasis. We found only letters, case reports and reviews on SIBO and these conditions, and no controlled studies.

Common questions

Can SIBO cause rosacea?

It has not been proven. SIBO is more common in rosacea in most studies2, and treating it helped in one trial with unblinded assessors1, but that does not show that SIBO causes rosacea.

What antibiotic was used for SIBO in rosacea?

Rifaximin, 1,200 mg a day for 10 days, in the 2008 trial1. It is the most studied antibiotic for SIBO; see our antibiotics guide.

Does rosacea come back after SIBO treatment?

In the 2008 trial, the improvement lasted at least 9 months1. SIBO itself often returns, so addressing its cause matters; see preventing SIBO relapse.

Works Cited & Scientific References 6
▼
  1. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication - Clin Gastroenterol Hepatol 2008 (PubMed)
  2. Prevalence and risk of small intestinal bacterial overgrowth in patients with rosacea: a systematic review and meta-analysis (in Russian) - Ter Arkh 2025 (PubMed)
  3. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea - United European Gastroenterol J 2015 (PMC)
  4. Evaluation of Helicobacter pylori and small intestinal bacterial overgrowth in subjects with rosacea - Cureus 2024 (PMC)
  5. An oral botanical supplement improves small intestinal bacterial overgrowth (SIBO) and facial redness: results of an open-label clinical study - Nutrients 2024 (PMC)
  6. Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis - Acta Derm Venereol 2013 (PubMed)